Apnimed, Inc.
APMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745648
In the last 90 days, Apnimed, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of APMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apnimed, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ameriprise Financial Inc | 13G | 18.90%7.48M shares | New | Aug 7, 20261 filing | Aug 7, 2026 | SEC |
| Tao Capital Management LP | 13G | 5.20%2.18M shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Apnimed, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 20263:04 PM ET | Ameriprise Financial Incand 2 others | 13G | 18.90%7.48M shares | New | Jul 31, 2026 | SEC |
| Aug 6, 20264:15 PM ET | Tao Capital Management LPand 3 others | 13G | 5.20%2.18M shares | New | Jul 31, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Apnimed, Inc. shares.
No Form 144 notices for Apnimed, Inc. are on file.